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Abstract
The BCR gene is implicated in the development of Ph-positive leukemia through its fusion with
the nonreceptor tyrosine kinase gene ABL. The normal 160 kDa Bcr protein has several functional
domains, and recently one specific role for Bcr was established in the regulation of respiratory
burst activity in white blood cells. Bcr expression levels are relatively constant throughout mouse
development until adulthood in brain and in hematopoietic tissues, a pattern that is distinctly
different from that of the functionally related n-chimerin gene. In the present study, RNA in situ
hybridization was used to explore the normal cellular function of Bcr in rodent brain and
hematopoietic organs. The data pinpoint the high bcr expression in the brain to the hippocampal
pyramidal cell layer and the dentate gyrus, and to the piriform cortex and the olfactory nuclei,
reflecting a potentially interesting function for Bcr in these highly specialized brain regions.
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INTRODUCTION
The human BCR locus was first identified in a break-point cluster region on chromosome 22
in Philadelphia (Ph) positive leukemia (Groffen et al., 1985; Heisterkamp et al., 1983):
through a t(9;22)(q34;ql 1) translocation, the BCR gene becomes fused with the ABL gene,
a nonreceptor tyrosine kinase normally located on chromosome 9 (Heisterkamp and
Groffen, 1991; Rowley, 1990). The leukemogenic role of BCR/ABL has been demonstrated
experimentally in transgenic mice carrying BCR/ABL fusion-transgenes and by retroviral
transduction experiments in which mice receive BCR/ABL-positive bone marrow
transplants (Daley et al., 1990; Elefanty et al., 1990; Heisterkamp et al., 1990; Voncken et
al., 1992).
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The BCR gene encodes a 160 kDa cytoplasmic protein with several functional domains and
is a protein likely to participate in signal transduction. Its N-terminal domain encoded by
exon 1 has a serine/threonine kinase activity, can oligomerize, and is capable of binding
other protein factors, including p145Abl (McWhirter et al., 1993; Sawyers et al., 1991). The
central part of Bcr has homology to the G-nucleotide exchange factor (GEF) Dbl, and the
carboxy terminal part is homologous to the n-chimerin protein, which is selectively
expressed in neuronal tissue (Diekman et al., 1991; Ron et al., 1991). As is the case for n-
chimerin, this domain of Bcr has GTP-ase activating protein (GAP) activity toward a
subfamily of p21Ras-related small GTP-binding proteins, p21Rho/Rac (Diekman et al.,
1991). Recently, we have established at least one function for Bcr as a regulator of p21Rac-
mediated superoxide production by the NADPH-oxidase in leukocytes (Voncken et al.,
1995).
In the mouse, bcr expression is detectable as early as the zygote stage, continues throughout
embryogenesis (unpublished observations), and is found in most adult tissues examined
(Heisterkamp et al., 1993). In man, BCR has also been shown to be ubiquitously expressed.
Notwithstanding its role in normal and leukemic blood cells (Campbell and Arlinghaus,
1991; Collins et al., 1987; Voncken et al., 1995), the Bcr protein is found in high levels in
the brain. This observation has intrigued us as it suggests a possible different function for
p160Bcr. This notion is corroborated by the seemingly highly significant function of G-
proteins in the brain (Hopkin, 1994). In an attempt to further delineate a putative cellular
function of Bcr in the brain, we have studied the regional expression of bcr in the rodent
brain by means of RNA in situ hybridization. We also report data on the expression kinetics
of bcr during mouse development in hematopoietic organs and in the brain.
MATERIALS AND METHODS
Tissue preparation
Paraffin embedded adult mouse brain sections were obtained from Novagen Inc. (Madison,
WI). Adult Sprague–Dawley rats were decapitated rapidly and the brains were removed onto
dry ice and stored at −80°C. Coronal sections (20 µm) were mounted on gelatine-coated
slides and stored at −80°C.
Probes
A 400-bp fragment of mouse bcr was amplified by RT/PCR with the primers ALLE
(Kawasaki et al., 1988) and BEX3 (5' AACCCACTTTCTCATCTCCAG 3') as previously
described.(Heisterkamp et al., 1990). The RT/PCR product was gel purified and digested
with EcoRI and Clal yielding a 251 -bp fragment that was subcloned directionally into pSK
(Stratagene). The identity of the cloned fragment was confirmed by sequencing both strands
using the Sequenase 2.0 system (USB). To obtain antisense and sense RNA probes, the
construct was linearized with BamHI (antisense) or Xhol (sense) and transcribed in vitro
with α-35SUTP using T7 and T3 RNA polymerase, respectively, essentially as described by
the manufacturer (Novagen Inc., Madison WI). A second bcr antisense RNA probe was
produced by digesting a 1 8-kb HindIII/EcoRI genomic fragment (Zhu et al., 1990) cloned
in pSK with Narl and transcription with T7 RNA polymerase. Probes were labeled to high
specific activity, typically 2.0 × 108 cpm/µg. The oligonucleotide probe BEX2 (5'
GAGGAAGAAGGTGAATCATCG 3') was labeled on the 3' end with 35SdATP using
terminal deoxy-nucleotidyl transferase (Bethesda Research Lab.). An oligonucleotide probe
for an unrelated gene, CRH, was similarly generated and labeled as specificity control
(Baram and Schultz, 1991; Yi et al., 1993).
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In situ hybridization procedures
In situ hybridization on paraffin-embedded mouse tissues was performed using the
SureSiteII System from Novagen. Briefly, paraffin was removed by three washes in xylene
and rehydrated through a graded ethanol series. Tissue pretreatment consisted of ribosome
disruption in 0.2 N HC1 for 5 min, deproteinization in 1 µg/ml proteinase K for 5 min,
followed by acetylation in 0.1 M triethanolamine-HCl, pH 8.0, containing 0.25% (v/v) acetic
anhydride for 5 min. Prehybridization, hybridization with antisense and sense probes on
parallel sections, and subsequent washings were performed according to the manufacturers
instructions. Slides were apposed to XAR2 films for 1–2 d, then dipped into Kodak NTB-2
emulsion, exposed in a sealed container for 2−3 weeks at +4°C, and finally developed and
fixed using Kodak developer D-19 and Kodak fixer, respectively. Slides were stained in 5%
aqueous Giemsa, examined and photographed with bright and darkfield optics using an
Olympus BH-2 microscope equipped with an Olympus C-35AD-2 camera. In situ
hybridization on rat brain sections using the oligonucleotide probes described above was
performed essentially as previously described (Baram and Schultz, 1991, 1992; Yi et al.,
1993). After prehybridization for 1 h and hybridization for 20 h at 40°C in a humidity
chamber, serial washes were performed (4 washes at 2×SSC for 15 min at 40°C, followed
by one wash in 1×SSC and one in 1×SSC at room temperature), followed by dehydration
through ethanol-0.3M NH4Ac and apposition to X-ray film (Hyperfilm B-max, Amersham)
for 24–48 h.
Northern blot analysis
Tissues from C57B1/6 × B6CBA F1 mice were minced in a polytron, and total RNA was
extracted using the acid guanidinium thiocyanate phenol-chloroform method (Chomczynski
and Sacchi, 1987). At embryonic day E15, E17, and E20 the head region was separated from
the remainder of the embryo. At parturition (P0) and postnatal day 1, 5, 10, 15, 20, 25, 30,
and 35, the entire brain including cerebellum was dissected. To compare the developmental
expression of bcr in the brain with bcr expression in hematopoietic tissue, RNA was
prepared from the liver at E15, E17, E20, at parturition, and from the spleen at postnatal day
1, 5, 10, 15, 20, 25, 30, and 35. Samples (10 µg) were run on formaldehyde/formamide gels,
blotted as described (Sambrook et al., 1989), and subsequently hybridized to the 1.8-kb
HindIII/EcoRI probe containing coding sequences from mouse bcr exon 1. Filters were
washed at low stringency (2.5×SSC, 65°C for 20 min). At this stringency the probe also
cross-hybridizes to the 28S and 18S ribosomal bands, making it possible to check for equal
loading of the lanes. Densitometric scanning was performed using an in-house manufactured
densitometric device.
RESULTS
In situ hybridization patterns
Coronal sections of adult mouse brain revealed specific hybridization mainly localized to
cells of neuronal morphology when hybridized with either of the two (nonoverlapping)
antisense bcr probes described above. The sense probe did not produce any specific signal in
any of the experiments performed. High concentration of bcr mRNA was present in
hippocampus, and to a somewhat lower degree in the cerebral cortex. In hippocampus and
dentate gyrus, region CA1–CA3, the pyramidal cell and granular cell layers were strongly
labeled (Figs. 1A and 1B). In the cortex, neurons in layers II–VI were moderately labeled
(not shown), whereas a stronger labeling was noted in the piriform cortex (Fig. 1C). Some
thalamic nuclei showed a weak hybridization (not shown). Neurons in amygdala and
hypothalamus were not labeled above background hybridization. The hybridization pattern
in the cerebellum was not investigated. In the rat, anterior olfactory nuclei displayed a
specific hybridization pattern (Fig. 1C). In situ hybridization with labeled oligo-nucleotides
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further revealed similar expression patterns to that of the mouse: dentate gyrus granular
cells, the hippocampal pyramidal layer (CA1–CA3 region), and the piriform cortex clearly
displayed a specific hybridization pattern, diminishing in intensity in the order indicated
above (Fig. 2).
Gene expression throughout development
Northern blot analysis of bcr expression in the mouse brain showed a transcript of
approximately 7 kb that was present at E15 and remained constant throughout the embryonal
period of development, as well as through postnatal days 1–35 (Fig. 3). Densitometric
scanning revealed no clear changes in her expression level over time, when corrected for
unequal loading on the basis of background hybridization to 18 and 28S ribosomal RNA.
The role of Bcr in blood cells has recently been validated (Voncken et al., 1995). Northern
blot analysis of liver and spleen samples, organs that have a distinct hematopoietic function
during embryogenesis and for some period after birth, showed a lower level of bcr
expression throughout the same developmental stages, but, similar to bcr expression in the
brain, the level remained constant throughout pre- and postnatal development (data not
shown).
DISCUSSION
The Bcr protein is a multidomain protein and is involved in Ph-positivc leukemogenesis
through its fusion to the nonreceptor tyrosine kinase Abl (Heisterkamp and Groffen, 1991;
Van Etten, 1993). Although we have recently established a function for Bcr in neutrophils,
the reason why bcr is highly expressed in the brain remains elusive. We have used in situ
hybridization to study bcr expression patterns in the rodent brain. Our data show that bcr is
highly expressed in the hippocampus and dentate gyrus, and to a lower level in the piriform
cortex and anterior olfactory nuclei.
Granule cells of the dentate gyrus are primarily generated postnatally. In rodents, granule
cells proliferate and differentiate almost exclusively in the first 2 postnatal weeks. In the
mouse and the rat, a small percentage of these cells is constantly generated in the adult
(Gage, 1994; Gould et al., 1994; and references therein). The hippocampus and olfactory
bulb are sites of postnatal neurogenesis and intense synaptic plasticity. Small GTP-binding
proteins as well as their regulatory molecules are frequently implicated in processes that
control cellular growth in tissues, including the brain. The constitutive activation of p21RAS
in neurofibromatosis by deactivation of neurofibromin (Basu et al., 1992; Bollag and
McCormick, 1992; DeClue et al., 1992), a GTP-ase activating protein (GAP) for RAS, is a
good example. The BCR gene itself has been implicated in human leukemia, and the BCR-
related ABR gene appears to be deleted in particular cancers (Isomura et al., 1994; Morris et
al., 1995; Saxena et al., 1992).
Although we cannot entirely exclude an involvement of Bcr in neuronal proliferation, the
developmental profile of Bcr expression and the presence of Bcr in postmitotic neurons of
the hippocampus suggests that Bcr functions also in the absence of neuronal proliferation.
Postmitotic neurons in bcr expressing regions, the olfactory bulb, cortex, and hippocampal
formation undergo intensive activity-related alteration of synaptic efficacy. It is intriguing to
consider a role for Bcr in energy-consuming processes underlying cellular mechanisms of
synaptic plasticity. We are currently examining this hypothesis by measuring neuronal Bcr
at baseline conditions and subsequent to physiological stress.
The C-terminal part of Bcr has a high degree of homology with that of n-chimerin, which,
like Bcr, possesses GTP-ase activity toward p21rac, a member of the RAS superfamily. The
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regional expression pattern of bcr in the brain overlaps in part that of n-chimerin. N-
chimerin expression is restricted to neurons, with the highest levels of expression in
hippocampal pyramidal cells, granulae cells of the dentate gyrus, in cortical neurons, and in
the Purkinje cells of the cerebellum (Lim et al., 1992). The developmental expression of bcr,
however, displays different dynamics than that of n-chimerin: whereas n-chimerin
expression rises sharply after birth to maximal levels at 20 d postpartum (Lim et al., 1992), a
period coinciding with cellular differentiation and synaptogenesis, bcr expression remained
constant from E15 through day 35 after birth. Northern blot analysis of hematopoietic
organs (liver and spleen) also revealed a constant level of bcr expression from embryonal
stage E15 throughout development until adulthood.
It is difficult to assess the significance of the relatively high level of bcr expression in the
hippocampal region of the brain. Recently, n-chimerin expression in the canary forebrain
was connected with seasonal changes in song learning and behavior; the conserved structure
and pattern of n-chimerin expression in the song circuit suggested a fundamental function
for this gene in the vertebrate forebrain and a role in the regulation of neural plasticity
(George and Clayton, 1992). In the young mouse brain, the developmental expression
pattern of n-chimerin seems to disclose a potential role in the development of particular
cognitive functions (Lim et al., 1992). The finding that bcr expression is more or less
constant throughout brain maturation would seem to point to a regulatory role of a more
fundamental character in cellular processes.
In the rodent brain, bcr mRNA in the hippocampus is most abundant in dentate gyrus cells,
lower in CA3, and lowest in CA1. The functional organization of the hippocampus is such
that input through the perforant path reaches granule cell layers. The granular cells, through
axons (mossy fibers), synapse on CA3 neurons, which then impinge on CA1. The gradient
of bcr expression levels along this functional neuronal path may reflect a potentially
interesting yet presently poorly understood function of Bcr in these highly specialized
structures.
A growing number of GTPases and GAPs has been implicated in brain biology over the
most recent years. Often these proteins (i.e. n-chimerin, α2-chimerin, Bcr, Abr) display a
brain-specific expression pattern (Hall et al., 1993; Leung et al., 1994; Lim et al., 1992; Tan
et al., 1993) or are, as described above, implicated in brain physiology (n-chimerin) or
neoplasia (neurofibromin). Members of the extended family of GTPases have also been
implicated in synaptic vesicle transport in nerve terminals (Liu et al., 1994; Von Gersdorff
and Matthews, 1994), further indicating the importance of such protein factors in
fundamental brain-related processes. This study, concurrent with the recently demonstrated
function of Bcr as a regulator of p21Rac-mediated superoxide production by the respiratory
burst oxidase in neutrophils (Voncken et al., 1995), suggests differences in tissue-specific
functioning of p160Bcr. Increased knowledge of these cellular function(s) of Bcr should
strengthen our understanding of the role of Bcr in leukocytes, its contribution to Ph-positive
leukemogenesis, and its biological relevance in the brain.
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Fig. 1.
(A) Darkfield photograph of a coronal section of a mouse brain showing strong
hybridization to the hippocampus (large arrow-heads) and dentate gyrus (small arrow-heads)
when hybridized wilh the antisense her probe. (B) Daikfield photograph of a parallel section
to the one presented in Fig. IA showing only weak background hybridization to the
hippocampus (large arrowheads) and no hybridization signal to the dentate gyrus when
hybridized with the sense bcr probe. (C) Magnifications of rat olfactory bulb (to the left) and
whole brain sections (to the right) showing specific hybridization of a bcr-specific
oligonucleotide to anterior olfactory nucleus and piriform cortex (arrows). Autoradiographic
image.
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Fig. 2.
Coronal section of the rat brain showing strong hybridization to the hippocampus (large
arrow-heads) and dentate gyms (small arrow-heads) when hybridized to the bcr
oligonucleotide (see the Material and Methods section). Reversed autoradiographie image.
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Fig. 3.
Autoradiogram showing a constant expression of bcr in the mouse brain from embryonal
day 15 (E15) to postnatal day 35 (P35). The bcr transcript of approximately 7 kb and the 28
and 18S ribosomal bands are indicated.
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